Results 201 to 210 of about 1,327,504 (271)
Continuous versus intermittent infusion of beta-lactam antibiotics: where do we stand today? A narrative review. [PDF]
Alawyia B +3 more
europepmc +1 more source
NLRP3 is a promising inflammatory target, but existing inhibitors lack diversity and brain penetrance, and none are approved. Using chemoproteomics, we discovered a novel series that binds to Cys463 in a previously uncharacterized pocket. Compounds showed nanomolar potency, brain exposure, and in vivo suppression of IL‐1β, supporting neuroinflammatory ...
Donald C. Rogness +21 more
wiley +1 more source
A retrospective analysis of bacterial pathogens in wounds in an equine hospital (2017–2022)
Summary Background Bacterial infections are a major cause of morbidity in horses, particularly in soft tissue wounds (STW) and surgical site infections (SSI). Rising antimicrobial resistance poses challenges for timely treatment. Knowledge of common pathogens and their resistance patterns is therefore essential.
J. Nebes +3 more
wiley +1 more source
ABSTRACT Silver‐containing wound dressings are among the most widely used topical antimicrobial interventions in chronic wound management. Amid escalating antimicrobial resistance and increasing scrutiny of antiseptic stewardship, there is growing debate regarding the prevalence and clinical relevance of bacterial resistance to silver, yet the ...
Michael Radzieta +5 more
wiley +1 more source
ABSTRACT Systemic antibiotics are effective when used as adjunctive therapy in the treatment of periodontitis; however, their use must be balanced against antimicrobial resistance, which is a major threat to global public health. This review provides an expert synthesis of the literature and a field‐level overview of antimicrobial resistance in ...
Meera Alghafri +3 more
wiley +1 more source
Beta-lactam antibiotics administration among adult inpatients with a beta-lactam allergy label: incidence, predictors, and outcomes. [PDF]
Epstein-Rigbi N +5 more
europepmc +1 more source
ABSTRACT Background & Aims YAQ001 is a novel, non‐absorbable, gut‐restricted, multiporous, carbon bead adsorbent. Pre‐clinical studies and a clinical trial suggested its therapeutic potential and safety in patients with cirrhosis. This substudy aimed to explore the effects of YAQ001 on the gut microbiome and their exploratory association with ...
Jinxia Liu +54 more
wiley +1 more source
Rise of the beta-lactams: a retrospective, comparative cohort of oral beta-lactam antibiotics as step-down therapy for hospitalized adults with acute pyelonephritis. [PDF]
Hobbs ALV +5 more
europepmc +1 more source
ABSTRACT Agrobacterium tumefaciens is a powerful delivery tool for plant genetic transformation and a pivotal platform for agricultural biotechnology. However, laboratory strains of Agrobacterium have remained genetically unoptimized for decades, with genome engineering hindered by inefficient, endogenous homologous recombination systems.
Minmin Zheng +4 more
wiley +1 more source

